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ABSTRACT
Background: There is a global crisis in male reproductive health. Evidence comes from globally declining sperm counts and
increasing male reproductive system abnormalities, such as cryptorchidism, germ cell tumors, and onset of puberty. Male factor
infertility occurs in ~40% of couples experiencing infertility. Data demonstrate an association between male infertility and overall
health. Associated significant health conditions include diabetes mellitus, metabolic disorders, and cardiovascular disease. Adding to
the complexity is that men typically do not seek health care unless there is acute medical need or, as in the case of the infertile cou-
ple, the male goes for a reproductive examination and semen analysis. However, 25% of the time a reproductive health examination
does not occur. Couples are increasingly utilizing IVF at more advanced ages, and advanced paternal age is associated with increased
risk for (i) adverse perinatal outcomes for both offspring and mother; (ii) early child mortality, cancer, and mental health issues. In
addition to age, paternal lifestyle factors, such as obesity and smoking, impact not only the male fertility but also the offspring
wellness.
Objectives: The purpose of this paper was (i) to spotlight emerging and concerning data on male reproductive health, the relation-
ship(s) between male reproductive and somatic health, and the heritable conditions father can pass to offspring, and (ii) to present a
strategic roadmap with the goals of increasing (a) the awareness of men and society on the aforementioned, (b) the participation of
men in healthcare seeking, and (c) advocacy to invigorate policy and funding agencies to support increased research into male repro-
ductive biology.
Conclusions: The Male Reproductive Health Initiative (MRHI) is a newly established and rapidly growing global consortium of key
opinion leaders in research, medicine, funding and policy agencies, and patient support groups that are moving forward the signifi-
cant task of accomplishing the goals of the strategic roadmap.
INTRODUCTION
Men’s health is globally in crisis and worsening due, in part, to
limited healthcare policies, ebbing research funding, and under-
developed societal awareness and education. Global health care
initiatives by the World Health Organization (WHO) and the
United Nations (UN) serve as meaningful and representative
examples for how policy enactment can act as a catalyst for glob-
ally increased social awareness and education to support health-
ier lives. For example, the WHO announced (September 2018)
that over USD$35 billion in financial commitments were made
to the “Every Woman Every Child Global Strategy for Women’s,
Children’s and Adolescent’s Health” (2016–2030) program. This
substantial financial resource has supported a highly successful
educational outreach program through which 377 million
women, children, and adolescents were reached. The UN’s 2030
Sustainable Development Goals (SDG) program is showing
steady progress toward achieving SDG 3 on health and well-be-
ing by, for example, demonstrating global improvement in nutri-
tion, reducing mortality, and ensuring reproductive health and
rights for women and children. The success of these programs
helps to reinforce what can also be accomplished for men’s
health. These initiatives also help to shed light on the presence
of a gender gap in healthcare policies and, thus, a need for more
gender-inclusive healthcare strategies (Hawkes & Buse, 2013;
Rovito et al., 2017). A recent publication (Baker, 2019) provides a
comprehensive report on the global state of men’s health, and
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some factors that contribute to and that are needed to be over-
come in order for men’s health to improve.
The field of reproductive biology, while a component of, for
example, the WHO and UN initiatives, has received less atten-
tion in policy, funding, and societal awareness and education
than other areas of the health sciences, for example, cancer and
cardiovascular disease. In spite of these limitations, researchers
have made remarkable progress in gaining a better understand-
ing of female reproduction, diagnosing associated disease states,
and developing effective therapies. This paper will specifically
focus on the critical state of men’s reproductive health and how
it is intimately connected with their overall health, how men’s
reproductive health can impact their female partner and future
generations, and it concludes with some current initiatives and
recommendations for advancement.
WHY IS MEN’S HEALTH IMPORTANT?
Globally, men on average have a shorter life expectancy as
compared to women (69.1 vs. 73.8 years, respectively)—“males
across the globe live sicker and die younger than females”
(Rovito et al., 2017). Contributing factors include reluctance of
men to seek healthcare advice and treatment and, in general,
unhealthy lifestyle factors. These are readily correctable factors
that could help to erase the live sicker die younger label. The dis-
parity in life expectancy between male and female has tremen-
dous impact not only on the family but also on the economy. In
the United States, many hundreds of billions of dollars are spent
by federal, non-federal, and employer-supported health plans to
support male chronic disease (Brott et al., 2011). Effecting
change in male attitude from reluctance to active and regular
participation in healthcare seeking would likely result in lower
morbidity and mortality and, as a consequence, a very substan-
tial monetary savings to national and global economies. Leone
et al (2017) conclude “it is in the US economy’s best interest, in
addition to being the morally correct position, to invest in
understanding how to augment men’s health through access,
participation, and prevention, with access being the linchpin to
action.”
Economics is not the only benefit to come from men more
actively seeking health care. For couples experiencing infertility,
the male factors into 40% of the cause of infertility yet very often
he lacks a current health and lifestyle profile much less a repro-
ductive health profile. Absence of early diagnosis and treatment
for a reproductive health issue or comorbidity can result not
only in greater healthcare cost but, importantly, often place the
burden of infertility treatment solely upon the woman. Thus,
men’s health extends beyond just the individual; men’s health is
very much a women’s health issue and a baby-born health con-
cern as well.
WHAT ARE SOME FACTORS THAT INFLUENCE MALE
PARTICIPATION IN HEALTH CARE?
Men characteristically fall second to women in seeking health
care. Male participation in health care is predominantly influ-
enced by the presence or absence of illness or injury, social
norms, and feelings of vulnerability to one’s masculinity (Maha-
lik et al., 2007; Mahalik & Backus Dagirmanjian, 2018). For exam-
ple, in the event of illness or workplace injury, a man may adopt
a “tough it out” attitude in an effort to retain and maintain one’s
sense of masculinity (Mahalik & Backus Dagirmanjian, 2018). If
a man feels that a physical examination might reveal known or
hidden illness, he may be reluctant to go because he identifies
that as a sign of weakness and contrary to his sense of masculin-
ity. Following along the same hegemonic masculine ideals, a
man may feel his masculinity threatened if there is question
regarding his fertility.
Social norms can play a positive role in help-seeking if, for
example, a partner or family member suggests that the man has
a routine physical examination and he sees other men doing the
same (Mahalik et al., 2007). This scenario may exist as it relates
to a couple’s pursuit of a remedy to childlessness through
assisted reproduction. The female partner is often said to be the
instigator and motivator for the male seeking help to investigate
his fertility potential. However, while the examination serves a
purpose for fertility evaluation, other pre-existing medical issues
may simultaneously be diagnosed for which the man was una-
ware because of his “caveman” attitude regarding participation
in health care. Reassuring, however, is a study by Farrimond
(2011), in which middle-class professional men were interviewed
for their thoughts and feelings on health, illness, and help-seek-
ing. The results were surprising in that any anticipation of a
threat to masculinity as being a deterrent to help-seeking was
not revealed. In contrast, the men reflected a “take action” atti-
tude regarding health and healthy lifestyle. Thus, perhaps there
is a change emerging regarding male self-awareness that will be
promotive of repealing the historic “caveman” attitude of men
toward help-seeking. If there is such an evolution, then it is
deserving of affirmation and support because there is a global
crisis in male reproductive health that demands urgent
attention.
THE PRESENT GLOBAL CRISIS IN MALE REPRODUCTIVE
HEALTH
A portent of potentially significant male reproductive health
issues is the global decline in sperm count being reported in a
growing number of scientific reports (Carlsen et al., 1992; Levine
et al., 2017). While the studies are retrospective, the consistency
in findings between them provides strong indication that sperm
counts are changing and trending negatively. These exemplar
reports serve as foundation for designing prospective, longitudi-
nal studies to investigate possible cause(s) of the historical
decline and to forecast what might be anticipated for the future.
In parallel with sperm count, decline is an equally unsettling and
persisting upward trend in male reproductive system abnormali-
ties, such as cryptorchidism, germ cell tumors, and onset of pub-
erty (Skakkebaek et al., 2016). Although these conditions are
likely to have complex relationships and the causes are far from
clear, it is alarming that the data are consistently negative and
effectively point in the same direction. It is simply not tenable to
ignore these data. If the negative trend in sperm counts and
male reproductive system problems has validity, then what
might that mean for male fertility as a whole and are there other
areas of concern regarding male reproductive health (Skakke-
baek et al., 2019)?
Teenage and young adult men are typically perceived as hav-
ing limited reproductive health care needs that require medical
attention. Often it is not until they have grown older, entered
into a relationship in which a baby is wanted and are unsuccess-
ful that they seek help to find the cause for the infertility
(Sonfield, 2002). Alarmingly, accumulating data have
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considerably strengthened an association between male subfer-
tility and somatic health (Jensen et al., 2009; Eisenberg et al.,
2015; Eisenberg et al., 2016; Hanson et al., 2017). For example,
Latif et al. (2017) examined 4712 men and evidence revealed that
impaired semen quality was significantly associated with long-
term morbidity. In a subsequent analysis (Latif et al., 2018), they
critically showed that this was largely independent of socioeco-
nomic status and lifestyle factors. A related and pertinent con-
clusion made by Choy & Eisenberg (2018) is “semen quality and
male infertility may be fundamental biomarkers of overall health
and could serve as harbingers for the development of comorbid-
ity and mortality.” Convincingly, a recent systematic literature
review (Capogrosso et al., 2018) demonstrated substantial evi-
dence of an association between male infertility and overall
health. Associated significant health conditions include testicu-
lar cancer, urogenital malignancies, diabetes mellitus, metabolic
disorders, and cardiovascular disease. The authors urge that
“Physicians should comprehensively assess men presenting for
couple infertility” given “their higher risk for developing cancer.”
Male infertility due to, for example, illness or environmental fac-
tors, is emerging as a potential key marker of systemic resilience
or lack thereof and, as such, its etiology is an essential compo-
nent to integrate into the complex, multifactorial paradigm of
preventive health care (Scheffer et al., 2018).
THE AGINGMALE AND OFFSPRINGWELLNESS
With assisted reproductive technologies serving as a fertility
safety net, there is an increased trend of couples delaying fam-
ily-building until later in life. For example, in the United States
during the decade from 2003 to 2013 childbirth increased in
women aged 35–39, 40–44, and 45–49 by 12%, 19%, and 60%,
respectively. During that same time, births to women 30–
34 years remained unchanged. For men, during the same time
period, paternity in ages 35–39, 40–44, 45–49, and 50–54
increased by 9%, 14%, 16%, and 8%, respectively. These data
appear to be consistent with global trends (Cedars, 2015). Ample
data are available regarding maternal age-related decline in fer-
tility, associated comorbidities, complications with pregnancy,
and risks to the neonate. In contrast, details are only beginning
to emerge regarding paternal age-related decline in fertility, pro-
found consequences for male reproductive health, and associ-
ated health risks (Simard et al., 2019). In fact, new research
papers on the topic are suggestive of a “tip of the iceberg” sce-
nario with the larger unseen contribution of the paternal iceberg
looming ominously.
A systematic review and meta-analysis (Johnson et al., 2015)
demonstrated an age-associated decrease in traditional semen
parameters and, in addition, an increase in sperm DNA frag-
mentation. For the latter, high levels of DNA fragmentation are
associated with reduced fertility and live birthrates. Khandwala
et al. (2017) showed that mean paternal age has increased in
the United States over the past 44 years from 27.4 to 30.9.
These same investigators (2018), in a follow-up study, reviewed
health records of over 40 million documented live births in the
United States from 2006 to 2016 to evaluate primary perinatal
outcome measures data, for example, gestational age, birth-
weight, and post-partum complications. Maternal perinatal
outcomes were also evaluated for gestational diabetes and
preeclampsia. The results surprisingly revealed an association
between advanced paternal age (45 years and older) at
conception with an increased risk of adverse perinatal out-
come measures of premature birth, low birthweight, and Apgar
scores. Further, the odds of maternal gestational diabetes were
over 30% higher in the mothers with the oldest male partner.
Collectively, these concerning health outcomes demand large-
scale investigations to identify the nature of the age-related
decline in semen parameters and, more importantly, how
spermatozoa from advanced paternal age fathers contribute to
increased risk of adverse perinatal outcomes for both offspring
and mothers. It merits emphasis that these paternally driven
adverse perinatal outcomes have significant health and finan-
cial cost to both the family and the society. As Khandwala and
colleagues conclude (2018), in the United States “The cumula-
tive risk over hundreds of thousands of births to older fathers
is also likely to be important in terms of both economic bur-
den and overall public health.” Extended globally, the influ-
ence of the aging father at conception on the many millions of
affected neonates and mothers will have a significant public
health impact and cause substantial economic strain, and
comprehensive data for both categories are urgently needed.
In addition to adverse perinatal outcomes associated with
increased paternal age at conception, there is also accumulating
evidence for health risk to the adolescent. Urhoj et al (2014) eval-
uated Danish registry birth and death data from 1978 to 2009 to
address the question of whether advanced paternal age has an
influence on offspring mortality. The results of their investiga-
tion showed an increased risk for <5-year-old child mortality
when the paternal age was >40 years. The cause of increased
death, for example, congenital malformations and malignancies,
while not significantly linked to advanced paternal age could
have been caused by point mutations due to advanced paternal
age. Thus, this plausible cause–effect mortality outcome merits
much greater investigation. The same research team investigated
the effect of paternal age at conception on offspring childhood
cancer (Urhoj et al., 2017). The Danish registry was evaluated for
children born between 1978 and 2010 for specific childhood can-
cers. Their results revealed that advanced paternal age
(>45 years) was associated with greater risk of <15-year-old chil-
dren developing acute lymphoblastic leukemia. No other types
of cancers were significantly associated with advanced paternal
age.
Oldereid et al. (2018) published results from a recent system-
atic review and meta-analysis investigating paternal age on
neonatal and pediatric outcomes. Overall, they concluded that
paternal age-associated increases in offspring serious adverse
outcomes were modest. However, after evaluating three previous
meta-analyses and 19 original investigations they found, based
on moderate certainty of evidence, that advanced paternal age,
for example, >40 years, is “probably associated” with both aut-
ism/ASD and schizophrenia. The reason for this association is
not specifically known but causative or contributing factors are
thought to be genomic, non-genomic (epigenetic), and
environmental.
The age-related, time of conception influence of the paternal
gamete on offspring bears closer investigation. First, a child will
have de novo point mutations not found in either parent. More
than 80% of these de novo mutations are paternal in origin (see,
de Ligt et al., 2013). In contrast, maternal de novo single
nucleotide mutations are transmitted to offspring at a much
lower frequency. The differences between male and female
© 2019 The Authors. Andrology published by John Wiley & Sons Ltd on behalf of
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gametogenesis that contribute to de novo mutations become
distinctly divergent with increasing parental age (Goldmann
et al., 2016). As father age-at-conception (20–40 years age)
increases so de novo single nucleotide mutations in the DNA
carried by his spermatozoa and they are passed to his offspring
at a rate of ~4% per year (Kong et al., 2012). Critically, as father
age-at-conception increases so then does the risk of a deleteri-
ous mutation being inherited by offspring that could lead to ASD
and schizophrenia.
Arslan et al. (2017) hypothesized, based on evolutionary
genetic history, that children born to older fathers would have
decreased survival and be less likely to have offspring. To investi-
gate their hypothesis, the authors evaluated three pre-industrial
western populations and found evidence for a paternal age effect
on both decreased offspring survival and decreased ability of
surviving offspring to reproduce, that is, reduced reproductive
fitness. They concluded that paternally driven de novo single
nucleotide mutations “reduce offspring fitness across popula-
tions and time periods.” In fact, the paternal age-associated
reduction in offspring reproductive fitness might be a critical
contributing factor to the globally declining sperm count that
has been trending over the past several decades. One parameter
unable to be investigated is the potential contribution of epige-
netic mutations to offspring outcomes. However, in that regard,
evidence is accumulating for paternally driven, transgenera-
tional genomic imprinting and epigenetic alterations in
offspring.
BEYOND THE MALE GENOME
The sperm epigenome is uniquely complex (Immler, 2018)
and susceptible to environmentally associated modification
(Schagdarsurengin & Steger, 2016) in part because there are vari-
ous points in the development that the epigenome is susceptible
to modification, that is, paternal embryonic development, sper-
matogenesis, and offspring early embryonic development (Gold
et al., 2018). At each time point, the internal and external envi-
ronments appear to have a major influence on how the epigen-
ome is modified (Soubry et al., 2014). For example, sperm DNA
methylation patterns have recently been shown to predict pater-
nal age with a high degree of accuracy (Jenkins et al., 2018). Pre-
liminary data suggest that environmental factors, such as
smoking, may alter DNA methylation patterns to an age beyond
actual chronologic age. As the database grows using this unique
sperm DNA methylation model (Jenkins et al., 2018), it will be
important to learn how lifestyle, that is, environmental factors,
may artificially age a man’s spermatozoa and, in consequence,
how it may impact the gestating fetus, neonate, and child.
Paternal age, smoking, obesity, and other life factors such as
pollution have been implicated as influencing the development
and wellness of offspring (Soubry et al., 2014). The worldwide
incidence of obesity has increased almost threefold since 1975
(WHO, https://www.who.int/news-room/fact-sheets/detail/obe
sity-and-overweight). Data show that obesity can cause or exac-
erbate male infertility (Campbell et al., 2015; Craig et al., 2017)
and the epigenetic signatures of obese men are markedly differ-
ent than lean men (Donkin et al., 2016). Alarming is that paternal
obesity is associated with (i) increased body fat in prepubertal
offspring (Figueroa-Colon et al., 2000), (ii) increased risk of off-
spring developing autism spectrum disorder (Murphy, 2014;
Suren et al., 2014), and on a molecular level, (iii) influences the
methylation pattern of specific loci of imprinting genes in off-
spring (Soubry et al., 2013; Soubry et al., 2015). Lastly, prelimi-
nary data suggest that the epigenetic profile of morbidly obese
men is dramatically altered following bariatric surgery and in
regions of the central nervous system attributed with control of
appetite (Donkin et al., 2016). To date, there are no published
data on wellness and development of offspring resulting from
fathers who underwent bariatric surgery.
Cigarette smoking is recognized as a modifiable global health
issue that contributes to chronic illness and premature death in
half of those that smoke (WHO, https://www.who.int/en/news-
room/fact-sheets/detail/tobacco). Smoking is also considered as
a male fertility risk factor. A recent paper reported data after a
comprehensive literature review on paternal smoking and
impact on offspring (Beal et al., 2017). In slightly more than half
of studies reviewed, no significant impairment in traditional
semen parameters was detected due to smoking. In contrast, the
remainder of studies (~40%) found evidence of modest impair-
ment in one or more semen parameters and especially as the
number of per day cigarettes smoked increased. Other studies
showed that for couples in which the male smokes the odds of
pregnancy after 6 months are lower than a non-smoking group.
For those couples where the man is a heavy smoker, the odds of
pregnancy after 12 months is lower than the non-smoking
cohort. In couples with known subfertility, male smoking con-
tributes to a 44% reduction in pregnancy rate after in vitro fertil-
ization. Smoking has perhaps its greatest negative impact on
genome integrity where 70% of publications reviewed reported
some level of smoking-related damage to the genome, for exam-
ple, increased DNA fragmentation and aneuploidy. One small
study reported that paternal smoking 6 months prior to concep-
tion was “four times more likely to pass tandem repeat min-
isatellite mutations to their children than non-smokers”
(Linschooten et al., 2013). Lastly, results from four meta-analyses
convincingly demonstrate that paternal preconception smoking
significantly increases cancer risk in offspring (Beal et al., 2017).
Assisted reproduction using the technique of in vitro fertiliza-
tion (IVF) is a multi-billion dollar global industry that has been
responsible for the birth of many millions of babies that might
not otherwise have been born. Male infertility is diagnosed in
approximately 40% of couples suffering from infertility. Compli-
cating matters is the estimation that in the United States almost
25% of males in an infertile couple do not undergo a male repro-
duction evaluation (Eisenberg et al., 2013). A recent meta-analy-
sis demonstrated that male infertility is associated with impaired
DNA methylation patterns (Santi et al., 2017). In more severe
forms of male infertility, for example, obstructive and non-ob-
structive azoospermia, a technique called intracytoplasmic
sperm injection (ICSI) is used to inject into the oocyte a single
spermatozoon judged by the ICSI operator as demonstrating
vitality and appearing normally shaped. Alarmingly, there is an
association between offspring conceived using IVF-ICSI and
imprinting disorders, such as Beckwith–Wiedemann and Angel-
man syndromes (Monk et al., 2019). While the aforementioned
IVF-ICSI-associated imprinting disorder outcomes require addi-
tional confirming or refuting large data studies, results from a
recent systematic review (Catford et al., 2018) of long-term fol-
low-up of offspring conceived through IVF-ICSI point in a simi-
lar direction for possibly both genomic and non-genomic
(epigenetic) impacts on neonatal well-being, for example,
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metabolic disorders and general health morbidities. Highlighted
in Catford et al. (2017) and in a previous systematic review by
the same group (Catford et al., 2017) is the critical need for more
comparable large datasets from high-quality studies in order to
draw strong-evidence conclusions.
In contrast to diagnosed male infertility, approximately 20–
30% of men evaluated for (in)fertility will have no definitive diag-
nosis, termed idiopathic infertility. A recent case–control study
reported an association between aberrant methylation of
imprinted genes and idiopathic infertility (Tang et al., 2018).
However, no follow-up on offspring born has been reported.
Therefore, a reasonable possibility exists that an unknown per-
centage of children born to fathers without a fertility diagnosis
may have occult paternally transmitted imprinting errors—and
these children may in turn transmit the errors to their future off-
spring (Champroux et al., 2018).
CURRENT INITIATIVES AND RECOMMENDATIONS
Beginning in late adolescence, for example, post puberty, male
medical examinations become much less frequent and occur
primarily because of acute-care need (Marcell et al., 2011). The
US National Institutes of Health’s MedlinePlus encyclopedia
topic for patients on health screenings for men ages 18–39, while
advocating for physical examination every 1–2 years, does not
include a male reproductive health assessment and recom-
mends against performing testicular self-examination (Review
Date 5/12/2018, https://medlineplus.gov/ency/article/007464.
htm). Given the increasingly cementing link between somatic
and reproductive health, we propose a new male preventive
healthcare paradigm for early teens and young adults, embraced
by healthcare funders, that (i) ensures continuity of medical care
from adolescence through early adulthood, when men are at
their most medically vulnerable due, in part, to infrequency of
surveillance, and (ii) a campaign that reinforces an annual physi-
cal examination combined with a reproductive health examina-
tion that includes semen analysis. To facilitate and encourage
male participation in healthcare seeking, Miner et al. (2018)
advocate for integrated health centers for men that provide com-
prehensive service and support for a man’s physical and mental
health needs.
Modernization is required not only of the healthcare system
but also of the healthcare funders as well, for example, private
insurance and national health programs. Healthcare funders
need convincing evidence that there is a financial benefit by
including the monitoring of male reproductive health, analogous
to what is offered for women, as part of an overall preventive
medicine program. By supporting such a paradigm shift, there
will likely be an increase in early detection of potentially chronic
or life-threatening disease states that can be mitigated through
lifestyle modification and, as a result, a decrease in payor
expense from otherwise high cost (potentially) curative medical
intervention, for example, surgery, chemotherapy, and radio-
therapy. This seems rather simple if one considers the exorbitant
costs associated with cancer treatments or chronic disease as
opposed to early detection through routine examination. The
financial cost of the current scenario versus the proposed male
reproductive preventive health program requires immediate
investigation to make determinations regarding benefit or not of
the latter proposed program. Until male-lifetime preventive
healthcare programs become globally entrenched, the
consequences from the status quo will be that the “live sicker
and die younger” label will continue to apply.
To secure the proposed paradigm shift in male heath care
requires the demand not only from men but also from society as
a whole. We assert that men, their families, and society, by and
large, are na€ıve to the significance of the “canary in the coal-
mine” scenario presented by declining sperm counts and, even
more, by the sentinel role that male reproductive health appears
to have for overall somatic health. If men, their partners, and
families are made more aware that routine male reproductive
health assessment can provide early detection of potential
chronic illness, disease, and cancer, then men may feel more
inclined to participate in a preventive healthcare program. Mod-
ern social media formats, educational systems, and the medical
community are the necessary voices to raise societal awareness
of the critical issues at hand. Some examples of annual social
programs to help raise awareness of male reproductive health
are as follows: for June, in the United States, is “Men’s Health
Month” (http://www.menshealthmonth.org) and, internation-
ally, “Men’s Health Week” (http://www.menshealthmonth.org/
imhw/imhw.html), and, in November, is the international male
health awareness program of Movember (www.movember.com).
Healthy Male (http://www.healthymale.org.au) is an Australian
government-funded program that provides information and
resources to raise awareness about male reproductive health and
associated chronic disease. The Australian government recently
reinforced their commitment to male reproductive health by
awarding substantial funding for the diagnosis of male infertility
and for Andrology Australia, $3.8M and $3M, respectively.
Women make ~80% of family healthcare decisions (Miner
et al., 2018), including those of her male partner. Increased
awareness by both men and women of male reproductive health
issues can positively affect the future of not only the man’s
health but also the health of the woman and their future chil-
dren’s health. “Men’s health is family health” (Miner et al.,
2018). Lastly, by increasing family and social awareness there is
the ripe opportunity to globally impact the future of men’s
health. Yet, social transformation is only part of the equation.
The evidence necessary to convince the healthcare system and
payors comes from scientific and clinical research, and therein
lays part of the problem. The use of ICSI in ART, where only a
single spermatozoon is required per egg, has contributed to a
diminished, more digitized role, that is, presence/absence of
spermatozoa, for the semen analysis. The role for clinical inter-
pretation of sperm numbers and quality of motion in therapeu-
tic decision-making has seemingly taken a back seat to a culture
of “DNA only” required. It merits highlighting that ICSI is not a
therapy. More critically, the ever-expanding “ICSI-all” approach
removes the equally shared burden of infertility treatment from
the couple and places it squarely, and wrongly, on the shoulders
of the woman alone. Specifically, she becomes potentially and
unnecessarily exposed to greater health and emotional risk. This
increasingly common and costly scenario serves as but one
example of a treatment regimen that could be lessened if health-
care providers had better diagnostic and therapeutic tools for
guiding male infertility evaluations. The tools required are
derived from research that translates from benchtop to bedside.
Although not entirely responsible, an additional impact of ICSI
has been to diminish, due to a perceived lessened need,
research funding to investigate sperm functional attributes and
© 2019 The Authors. Andrology published by John Wiley & Sons Ltd on behalf of
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requirements for fertilization (Barratt et al., 2018). This is a criti-
cal lapse for a number of reasons (see Barratt et al., 2017). First,
there is the basic human desire to learn more about how we
humans come to be. Second, by enhancing our knowledge
regarding sperm attributes that are essential for fertilization the
greater the opportunities for developing better diagnostic tools
for infertility detection and therapeutic intervention. Third, on
the reverse side of the same coin, better understanding of sperm
function leads to a greater ability to develop more specific and
highly effective reversible male contraceptive agents. This brief
correspondence should provide clear and convincing evidence
to motivate funding agencies to refocus and reallocate funds to
stimulate and support greater investigation into male reproduc-
tive health.
SUMMARY
This paper has presented evidence that there is a present and
growing global crisis in male reproductive health. Numerous sci-
entific publications report that chronic illness, disease, and pre-
mature death in men are linked to their reproductive health.
Further, emerging data demonstrate that the wellness of the
female partner, their offspring, and grand-offspring all have con-
nections to partner/father reproductive health. These male-
borne health issues are increasing at an alarming rate.
The Male Reproductive Health Initiative (MRHI) is a newly
established and rapidly growing consortium of key opinion lead-
ers in research, medicine, funding and policy agencies, and
patient support groups. The goals of the MRHI are to raise the
awareness of society, policy and funding agencies, and others to
(i) the significance of male reproductive health, (ii) the connec-
tion with overall male health and illness, (iii) the role the male
has in the health and wellness of his offspring and the next gen-
eration, and (iv) help alleviate the significant burden that is cur-
rently carried by his female partner when seeking diagnosis and
treatment for infertility. If action is not taken, and swiftly, then
men will continue to die younger, suffer longer with chronic dis-
ease and will, unwittingly, continue to pass their potentially
altered genomic and epigenomic signatures to future genera-
tions. Men’s health is global community health!
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